Oncology Podcast

Setting up for treatment success: Podcast on management of patients receiving VEGFR-TKI treatment for select solid tumours

Managing patients both pre- and during VEGFR-TKI treatment is an important consideration. Members of GI NURSES CONNECT and GU NURSES CONNECT give their views as to how nurses can play a key role in setting patients up for treatment success.

Veerle Lamotte

Paola Belardi

Publication Date

Oct 2021

I agree that this educational programme:

Was valuable to me

1/4

Has improved my knowledge of this topic:

2/4

Is likely to change my clinical practice:

3/4

Was balanced and unbiased:

4/4

Listen and follow our podcasts on:

Listen on Apple Podcasts

Listen to the podcast

In this educational podcast, Veerle Lamotte and Paola Belardi share their successful experience of managing patients treated with VEGFR-TKIs for select solid tumours.

The short 15-minute discussion captures and provides you with their useful insight on:

1. The safety profile of VEGFR-TKIs alone or in combination with PD-1 inhibitors in hepatocellular cancer (HCC), differentiated thyroid cancer (DTC) & advanced renal cell carcinoma (RCC) and how to recognise side effects & understand appropriate management

2. How to best manage patients both prior to & during treatment to ensure optimal treatment success, including prehabilitation of patients prior to treatment & management of side effects on treatment

Veerle and Paola have many years nursing experience and present views not only from the perspective of the nurse, but also with relevance across geographies.

This is the first collaboration between GI NURSES CONNECT and GU NURSES CONNECT on an educational programme offering a valuable resource that is not limited to one tumour type.

This GI NURSES CONNECT and GU NURSES CONNECT podcast is also available on
Castos, Spotify, Apple Podcasts, and Google Podcasts.

Veerle Lamotte has worked as an oncology nurse practitioner at Antwerp University Hospital since 2013. She graduated as a nurse in 2001, working initially in intensive care before moving to work in oncology in 2010. Veerle supports and guides patients within the tumour cluster uro-oncology care process; from diagnosis, during treatment, follow-up phase and at relapse. As an oncology nurse she has detailed knowledge and experience of urology, oncology and palliative care. Veerle is also a board member of UROBEL (the Belgian National Association for Urological Nurses) which keep nurses in Belgium informed about new strategies in uro-oncological healthcare.

Veerle Lamotte has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Ipsen and Pfizer.

Paola Belardi is a Nurse Co-ordinator at San Donato Hospital in Arezzo, Italy. Paola gained her first level Nursing Degree at the University of Siena in 2000. Later, in 2002 she attended a Public Health class at the University of Florence and in 2010 she graduated the Master Degree in Management at the University of Siena. In 2013 she started her work in oncology setting and now she is principally committed in activities such as nurse staffing and quality standard in oncology. From 2018 she is also an adjunct professor teaching Oncology Nursing at the University of Siena. Her professional interests are: chemotherapy and target therapy side effects management, intravenous devices management and nurses education. In the last month she has been co-supervisor of two Nursing Degree thesis: one studying the nurses’ role in fatigue prevention and the other regarding the nurses’ level of knowledge about simultaneous care model.